B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: Insights from the Acute Decompensated Heart Failure National Registry
American Heart Journal, 05/14/2012Kociol RD et al.
Higher B–type natriuretic peptide (BNP) level upon admission with heart failure (HF) among older patients without atrial fibrillation (AF) was associated with increased risks of myocardial infarction (MI) and mortality; however, higher BNP level was not associated with subsequent thromboembolism or stroke.
Authors linked data from the ADHERE registry for 2003 through 2006 with Medicare claims to identify patients ≥65 years who were hospitalized with HF, did not have AF, and did not receive warfarin at discharge.
They estimated rates of all–cause mortality, thromboembolic events, myocardial infarction (MI), and stroke using Kaplan–Meier methods and the cumulative incidence function.
They used Cox models to assess associations between log BNP level and each outcome after adjustment for potential confounders.
The study population included 11,679 patients from 146 sites.
Patients in the highest quartile of BNP level were older and more often male and African American.
They had higher rates of coronary artery disease, renal insufficiency, and peripheral vascular disease and lower rates of diabetes mellitus and chronic obstructive pulmonary disease.
After multivariable adjustment, each 30% increase in BNP level was associated with increased risks of death (hazard ratio 1.07, 95% CI 1.05–1.08) and MI (1.07, 1.04–1.10) but not thromboembolism or stroke.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.